Learn more about our 2023 Summer EPGRAD Program. New PhD and MS in Health and Biomedical Data Science program descriptions here. More information about the MS in Health and Biomedical Data Science here.
Learn more about our 2023 Summer EPGRAD Program. New PhD and MS in Health and Biomedical Data Science program descriptions here. More information about the MS in Health and Biomedical Data Science here.
The vision of the Department of Biostatistics and Bioinformatics is to improve public health through excellence in education and teaching in biostatistics and bioinformatics, transformative scientific research, and dedicated service to the university, profession and community. With Department faculty that have received more research funding than any other department at the university, the Department educates the next generation of leaders in biostatistics and bioinformatics by providing opportunities for close interactions with award winning faculty and practical real-world training opportunities in clinical trials, observational studies, diagnostic studies, and bioinformatics and computational biology. The initiation of the Department of Biostatistics and Bioinformatics highlights the school’s commitment to the quantitative sciences and the university-wide focus on science, technology, engineering and math (STEM).
Our ProgramsBiostatistics is the science of designing, conducting, analyzing and interpreting studies aimed at improving public health and medicine. Bioinformatics is the science of developing and applying computational algorithms and analysis methodologies to big biological data such as genetic sequences. Together they are foundational sciences for public health research and decision-making, and essential to the education of the next generation of leaders in public health and medicine.
Department Chair and Professor
Dr. Scott Evans is a Professor of Biostatistics and Bioinformatics and the Director of the George Washington Biostatistics Center. His interests include the design, monitoring, analyses, and reporting of and education in clinical trials and diagnostic studies. He is the author of more than 100 peer-reviewed publications and three books on clinical trials including Fundamentals for New Clinical Trialists.
Scott Evans BioProvides leadership and expertise in the execution of clinical trials, observational studies, and diagnostic studies across varied areas of expertise.
Learn MoreProvides cutting edge research and enables broad educational activities in computational biology.
Learn MoreProvides biostatistical and epidemiologic support.
Learn MoreDr. Ionut Bebu
Dr. Ionut Bebu is an Associate Research Professor develops statistical methodologies for cost-effectiveness analyses. He recently applied these methods to data from the studies conducted by the Biostatistics Center to determine the optimal screening frequency for diabetic retinopathy. The results were published in the New England Journal of Medicine.
Dr. Marcos Perez-Losada
Dr. Marcos Perez-Losada is an Associate Professor in evolutionary and computational biology working on applied issues in translational medicine. He is characterizing the microbiome of the human respiratory airways and the host inflammatory and immune responses during asthma and bronchiolitis. Dr. Perez-Losada has also received an award from the GWSPH Master Teaching Academy Fellows to develop an innovative project to teach hands-on genomics.
Dr. Heather Hoffman
Dr. Heather Hoffman is a Professor and Vice Chair of the Department of Biostatistics and Bioinformatics that has received awards for Excellence in Teaching and is a member of the Master Teachers Academy in the Milken Institute School of Public Health. Dr. Hoffman is the MPH Biostatistics Program Director and serves as Chair of the departmental Curriculum Committee. Her research interests include biostatistics education, recently presenting results comparing student performance and preference in an error-free versus an error-full SAS programming environment.
WASHINGTON (Sept 21, 2022) -- In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes , researchers found that insulin...
WASHINGTON, D.C. (July 15, 2020) — The GW Biostatistics Center recently launched three projects to design, conduct, analyze and report on COVID-19 studies.
WASHINGTON, DC (May 6, 2020) – Milken Institute SPH researchers are developing a deep learning bioinformatics platform that will help ...